Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01290419Phase 1Completed
Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine
Respiratory Syncytial Virus Infections
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Healthcare Discoveries d/b/a ICON Development Solutions

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Wisman

Pediatric Research of Charlottesville

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

lanjuan li

Shulan (Hangzhou) Hospital

Moderately Similar
6 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Michael Bell

Accel-West Volusia Pediatrics

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Jeffrey Stewart

Family Medical Associates

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Robert Cohen

Association Clinique et Thérapeutique Infantile du Val de Marne

Moderately Similar
3 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Ruth A. Karron, MD

Johns Hopkins Bloomberg School of Public Health

Moderately Similar
9 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Pui Leung

Quotient Clinical

Moderately Similar
3 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

William Simon

New Medical Healthcare

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Oliver Medzihradsky, MD MPH MS

Meissa Vaccines, Inc.

Moderately Similar
3 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Gates MRI

Gates Medical Research Institute

Moderately Similar
11 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01290419Phase 1PrincipalInvestigator

Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine

Respiratory Syncytial Virus Infections
Completed

All 1 trials loaded